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E-mail: christine.wenneras@microbio.gu.seIntroductionThe aim of this review is to summarize the current knowledge
on Candidatus Neoehrlichia mikurensis, a tick-borne bacterium
that has recently been shown to be pathogenic for humans. The
bacterium and its vectors, reservoirs, and modes of trans-
mission, and the infectious disease neoehrlichiosis and its clinical
picture, choice of diagnostics, and therapy, will be discussed.The agentC. Neoehrlichia mikurensis is a new bacterial species within the
novel genus Neoehrlichia, which belongs to the family Ana-
plasmataceae, order Rickettsiales [1]. There are six genera within
the Anaplasmataceae: Ehrlichia, Anaplasma, Wolbachia, Neo-
rickettsia, Aegyptianella, and Neoehrlichia. C. Neoehrlichia
mikurensis was named on the basis of its resemblance to the
genus Ehrlichia and the fact that it was isolated on the JapaneseClinical Microbiology and Infection © 2015 European Society of Cisland of Mikura; the term ‘Candidatus’ indicates that this bac-
terium is currently uncultivable [1]. Prior to the Japanese study,
C. Neoehrlichia mikurensis was described, but under other
alternative designations: Ehrlichia-like organism [2–4]; Ehrlichia-
like sp. Schotti variant [3,5]; Ehrlichia-like sp. Rattus variant [6];
and Candidatus Ehrlichia walkerii [7]. The closest relative of C.
Neoehrlichia mikurensis is the other species within the Neo-
ehrlichia genus, Candidatus Neoehrlichia lotoris, the natural host
of which is the raccoon [8].
C. Neoehrlichia mikurensis infects both invertebrates (ticks)
and vertebrates (humans, rodents, and dogs). As C. Neo-
ehrlichia mikurensis has not been cultivated to date, there is
limited information regarding its morphology, cellular tropism,
and life cycle. Like all other members of the Anaplasmataceae
[1], C. Neoehrlichia mikurensis is assumed to be a Gram-
negative obligate intracellular bacterium. Electronmicrographs
of the tissues of infected rats have revealed rounded, pleo-
morphic structures of diameter 0.5–1.2 μm within the splenic
sinusoids, which may be C. Neoehrlichia mikurensis [1]. How-
ever, as these structures were not labelled with DNA probes
or antibodies, it was not formally proven that they were C.
Neoehrlichia mikurensis, although they appeared to contain
DNA and ribosomes [1].
The target cells of C. Neoehrlichia mikurensis infection in
humans have not been identiﬁed with certainty, but the primeClin Microbiol Infect 2015; 21: 621–630
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2015.02.030
622 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIsuspects are leukocytes and endothelium. Using transmission
electron microscopy, Pekova et al. demonstrated coccoid
structures within the circulating granulocytes of infected pa-
tients [9]. Although this could be taken to indicate that C.
Neoehrlichia mikurensis infects granulocytes, it might simply
reﬂect the normal phagocytic function of neutrophils.
‘Morulae’, which are the intracellular inclusions observed inside
human leukocytes that are infected with Anaplasma phag-
ocytophilum or Ehrlichia chaffeensis, have never been detected in
patients with neoehrlichiosis. Regarding the endothelium, there
are two case reports of C. Neoehrlichia mikurensis infection
with associated arterial aneurysms, although, in both cases, it
was not possible to determine whether C. Neoehrlichia
mikurensis was the cause of the aneurysms [10,11]. To date, C.
Neoehrlichia mikurensis has not been detected inside the walls
of human blood vessels [11], and it has not been cultivated
successfully in endothelial cell lines (or any other cell line for
that matter).The epidemiology of C. Neoehrlichia
mikurensis infections of ticks and rodentsC. Neoehrlichia mikurensis is widespread among ticks and ro-
dents in Europe and Asia. It has been detected in Mongolia [12],
China [6,12,13], Japan [1,14], Russia [4,5,15,16], the Czech Re-
public [9,17,18], Slovakia [19–21], Moldova [22], Hungary
[23–25], Austria [18,26], Germany [11,27–32], Switzerland
[33–37], Poland [38,39], Romania [40], France [28,41,42],
Belgium [43], Italy [44–46], Spain [47], The Netherlands
[3,42,43,48], and the Scandinavian countries [2,10,42,49–52]. It
has not been detected in theUK [43,53,54], theUSA, orAustralia.
Most European studies have indicated that C. Neoehrlichia
mikurensis is the third most common tick-borne human path-
ogen after Borrelia and Rickettsia species [33,44,55]. Estimates of
the prevalence of C. Neoehrlichia mikurensis among ticks are
shown in Table 1. C. Neoehrlichia mikurensis-infected ticks may
be co-infected with other pathogenic species, such as Borrelia,
Babesia, Rickettsia, and Anaplasma [14,26,28,31,44,49,56]. The
rate of co-infection of ticks with C. Neoehrlichia mikurensis and
Borrelia species is higher than predicted, and it may be more
common for C. Neoehrlichia mikurensis to occur together with
Borrelia than to appear alone in ticks [28,49,55]. This is probably
a consequence of the feeding of ticks on rodents that are
infected with both pathogens.
The prevalence of C. Neoehrlichia mikurensis seems to be
increasing: a monthly surveillance study of infection rates of
questing ticks conducted at 22 sites in The Netherlands be-
tween 2006 and 2010 revealed an increasing prevalence of C.
Neoehrlichia mikurensis, in contrast to the stable prevalenceClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectrates of the other studied pathogens, including Rickettsia helve-
tica, Borrelia species, Babesia species, and A. phagocytophilum
[55]. Although the ﬁrst published report of this new species
appeared in 1999 [3], these bacteria have been detected in a
tick collection from 1960 [22].
The prevalence of C. Neoehrlichia mikurensis infection
among rodents and ticks shows a seasonal pattern. In Germany,
none of the tested rodents carried C. Neoehrlichia mikurensis
in the period from March to May, 50% tested positive in June,
and the prevalence rates peaked in August (76%) and thereafter
declined to 36% in November [31]. In Sweden, C. Neoehrlichia
mikurensis infection among bank voles followed the same
pattern: a monthly increase in infection rate was noted from
May (8.7%) and in subsequent months, reaching a maximum in
September (54%) [56]. Similarly, the highest rate of C. Neo-
ehrlichia mikurensis infection of ticks was seen in October in
The Netherlands [55].
Studies on the genetic diversity of C. Neoehrlichia mikurensis
have mainly been focused on the 16S rRNA and groEL genes
[11,12,15,35,39]. Comparative analyses of the deposited
nucleotide sequences of C. Neoehrlichia mikurensis indicate
that the genotypes circulating in Asia (China, Japan, and Siberia)
are different from those seen in Europe [11,12]. This may partly
be explained by the ﬁnding that the species of Ixodes ticks
commonly found in Asia (Ixodes persulcatus and Ixodes ovatus)
harbour different genotypes from the European Ixodes ricinus
[11]. In addition, three clusters of C. Neoehrlichia mikurensis
were identiﬁed in China, on the basis of phylogenetic analyses
of bacterial DNA recovered from rodents, ticks, and infected
humans [12].Vectors, reservoirs, and transmissionSeven species of ticks have been reported to be infected by C.
Neoehrlichia mikurensis: I. ricinus [48]; I. persulcatus [5,15];
I. ovatus [1]; Ixodes frontalis [57]; Ixodes hexagonus [30]; Derma-
centor reticulatus [29,30]; and Haemaphysalis concinna [13]. It
should be emphasized that the infection rates of C. Neoehrlichia
mikurensis are highest among the Ixodes species, indicating that
these are the primary vectors; the importance of the other tick
genera as vectors is disputable, as they rarely carry C. Neo-
ehrlichia mikurensis (Table 1).
The life stage of the tick does not seem to inﬂuence the
infection rate of C.Neoehrlichia mikurensis. Whereas one study
showed that nymphs were twice as likely to be infected by C.
Neoehrlichia mikurensis as were adult ticks [28], the opposite
pattern was seen in another study [31], and no difference in rates
of infection between the life stages was observed in a third study
[49]. C. Neoehrlichia mikurensis-infected ticks have beenious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 621–630
TABLE 1. Estimated prevalence rates of Candidatus Neoehrlichia mikurensis in ticks worldwide
Country
Ticks
ReferencesSpecies Source No. investigated (pooled)a Prevalence (%)
Austria Ixodes ricinus Questing 19/86 22 [18]
I. ricinus Questing 22/518 (10) 4.2 [26]
Belgium I. ricinus Questing 6/373 1.6 [43]
China Ixodes persulcatus Questing 6/316 1.9 [13]
Haemaphysalis concinna Questing 2/187 0.8 [13]
Czech Republic I. ricinus Questing 3/138 2.2 [18]
I. ricinus Questing 54 pools (3–5) 0.4–4.4 [17]
I. ricinus Questing 2/20 10 [28]
France I. ricinus Questing 1/60 1.7 [28]
Germany I. ricinus Wild boars 1/16 6.2 [32]
I. ricinus Dogs 32/773 4.1 [30]
Ixodes hexagonus Dogs 10/151 6.6 [30]
Dermacentor reticulatus Questing 1/1237 0.08 [30]
I. ricinus Questing 13/192 6.8 [27]
D. reticulatus Questing 0/283 0 [27]
I. ricinus Questing 44/542 8.1 [28]
I. ricinus Humans 9/111 8.1 [28]
I. ricinus Rodents 32/918 3.5 [29]
D. reticulatus Rodents 1/40 2.5 [29]
I. ricinus Questing 51/2315 2.2 [29]
Hungary I. ricinus Questing 3/34 8.8 [25]
D. reticulatus Questing 0/64 0 [25]
H. concinna Questing 0/62 0 [25]
Italy I. ricinus Humans 10/357 2.8 [7]
I. ricinus Humans 2/64 3.1 [46]
I. ricinus Questing 20/193 10 [44]
Moldova I. ricinus Questing 1/126 0.79 [22]
The Netherlands I. ricinus Roe deer 8/121 6.6 [3]
I. ricinus Questing 21/180 12 [48]
I. ricinus Humans 31/289 11 [59]
I. ricinus Questing 300/5343 5.6 [55]
I. ricinus Questing 160/2002 8.0 [43]
I. ricinus Red deer 26/409 6.4 [43]
I. ricinus Wild boar 4/84 8.3 [43]
I. ricinus Sheep 33/264 12 [43]
I. ricinus Mouﬂon 10/233 4.3 [43]
Norway I. ricinus Questing 8/341 2.3 [2]
Poland I. ricinus Questing 3/1325 (10) 0.23 [38]
I. ricinus Questing 0/40 0 [28]
Portugalb I. ricinus Questing 0/101 0 [28]
Russia I. persulcatus Questing 2/53 3.8 [5]
I. ricinus Questing 21/295 7.1 [4]
Ixodes frontalis, I. ricinus Birds 2/139 1.4 [57]
I. persulcatus Questing 8/3552 0.22 [15]
I. persulcatus Questing 5/2590 0.19 [16]
Slovakia I. ricinus Questing 47/1311 3.6 [18]
I. ricinus Questing 16/670 2.4 [21]
I. ricinus Questing 2/68 2.9 [19]
Spain I. ricinus Cows 2/200 1.0 [47]
Sweden I. ricinus Questing 57/949 6.0 [49]
Switzerland I. ricinus Birds 7/215 3.3 [37]
I. ricinus Questing 1916 (5–10) 3.5–8.0 [36]
I. ricinus Questing 52/818 6.4 [33]
UK I. ricinus Questing 0/954 0 [54]
D. reticulatus Questing 0/61 0 [53]
Haemaphysalis punctata Questing 0/100 0 [53]
I. ricinus Various 0/338 0 [43]
D. reticulatus Various 0/63 0 [43]
aNumber of ticks per pool.
bMadeira Island.
CMI Wennerås C. Neoehrlichia mikurensis 623collected from birds and a variety of mammals (Table 1), all of
which may facilitate the spread of the infection in the
environment.
Transmission of C. Neoehrlichia mikurensis to humans is
surmised to occur via tick bites, as ticks infected with similar or
identical sequence variants have been found in the surroundings
of infected persons [11,13,36]. Although many patients recall
speciﬁc tick bites [10], this is not always the case [10], as is
typical for tick-borne infectious agents [58]. Studies on the
prevalence of C. Neoehrlichia mikurensis in ticks removed from
people in The Netherlands [59] and Germany [28] haveClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyestimated that every ninth to 12th tick bite represents a risk of
transmission of C. Neoehrlichia mikurensis, although the risk of
becoming infected is likely to be considerably lower [59].
Infected ticks and rodents have been found in the vicinity of
large cities, such as Berlin, Budapest, Guangzhou, Leipzig, and
Zurich, indicating that large populations may be exposed to this
new infectious agent [6,24,30,31,36,60].
Until 2014, C. Neoehrlichia mikurensis had not been found in
the larval stage of ticks [43], and it had been inferred that it is
not transmitted transovarially [30]. However, it was recently
reported that four of ten larvae sampled in Austria wereand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 621–630
TABLE 2. Estimated prevalence rates of Candidatus Neoehrlichia mikurensis in rodents worldwide
Country
Rodents
ReferencesSpecies Common name No. investigated Prevalence (%)
China Rattus norvegicus Brown rat 3–4/15 20–27 [6]
Apodemus agrarius Striped ﬁeld mouse 14/117 12 [12]
Apodemus sylvaticus Wood mouse 5/40 12 [12]
Apodemus draco South China ﬁeld mouse 1/7 14 [12]
Apodemus peninsulae Korean ﬁeld mouse 5/57 8.8 [12]
Eothenomys custos Southwest China vole 2/8 25 [12]
Myodes rufocanus Grey red-backed vole 4/83 4.8 [12]
Niviventer confucianus Chinese white-bellied rat 1/52 1.9 [12]
R. norvegicus Brown rat 1/87 1.1 [12]
Tamias sibiricus Siberian chipmunk 1/7 14 [12]
Clethrionomys rufocanus Grey red-backed vole 5/109 4.6 [13]
R. norvegicus Brown rat 2/35 5.7 [13]
T. sibiricus Siberian chipmunk 1/3 33 [13]
France Myodes glareolus Bank vole 5/276 1.8 [41]
Germany M. glareolus Bank vole 16/56 29 [30]
Microtus arvalis Common vole 4/11 36 [30]
Microtus agrestis Field vole 2/2 100 [30]
Apodemus ﬂavicollis Yellow-necked mouse 10/82 12 [30]
Apodemus agrarius Striped ﬁeld mouse 4/78 5.2 [30]
Apodemus ﬂavicollis Yellow-necked mouse 24/37 65 [31]
Apodemus agrarius Striped ﬁeld mouse 1/3 33 [31]
M. glareolus Bank vole 23/42 55 [31]
M. glareolus Bank vole 125/396 32 [29]
Apodemus sylvaticus Wood mouse 1/36 2.8 [29]
Apodemus ﬂavicollis Yellow-necked mouse 50/178 28 [29]
Microtus arvalis Common vole 4/7 57 [29]
Hungary Apodemus ﬂavicollis Yellow-necked mouse 3/67 4.5 [25]
Apodemus agrarius Striped ﬁeld mouse 3/92 3.3 [25]
Italy Clethrionomys glareolus Bank vole 1/34 2.9 [45]
Japan Apodemus speciosus Large Japanese ﬁeld mouse 5/55 9.1 [14]
Apodemus argenteus Small Japanese ﬁeld mouse 2/7 28 [14]
R. norvegicus Brown rat 7/15 47 [1]
The Netherlands Apodemus sylvaticus Wood mouse 5/23 22 [43]
Microtus arvalis Common vole 2/8 25 [43]
M. glareolus Bank vole 4/35 11 [43]
Russia M. rufocanus Grey red-backed vole 1/606 0.17 [16]
Apodemus peninsulae Korean ﬁeld mouse 3/236 1.3 [16]
Microtus spp. Vole 1/38 2.6 [16]
Slovakia Apodemus spp., M. glareolus Mice and voles 31/286 11 [20]
Apodemus spp., C. glareolus Mice and voles 0/30 0 [19]
Sweden M. glareolus Bank vole 50/261 19 [56]
M. glareolus Bank vole 64/705 9.1 [50]
Microtus agrestis Field vole 2/24 8.3 [50]
Apodemus sylvaticus Wood mouse 1/10 10 [50]
Apodemus ﬂavicollis Yellow-necked mouse 1/25 4.0 [50]
Switzerland Apodemus spp., M. glareolus Mice and voles 8/100 8.0 [34]
624 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIinfected with C. Neoehrlichia mikurensis [18], implying the
possibility of transmission of C. Neoehrlichia mikurensis from
one generation of ticks to another; alternatively, the larvae may
have become infected after interrupted feeding on an infected
rodent. Whether transovarial transmission exists is still an open
question, and it is generally assumed that C. Neoehrlichia
mikurensis is dependent on a reservoir host for its survival.
Burri et al. have proven that wild rodents are competent hosts
for C. Neoehrlichia mikurensis, by showing that seven of eight
naturally infected wild rodents could transmit the infection to
pathogen-free ticks reared in the laboratory [34]. Moreover,
they demonstrated double transmission of infection, in that one
rodent was shown to transmit both Borrelia afzelii and C.
Neoehrlichia mikurensis to the laboratory ticks.
Most species of wild rodents have the potential to serve as
hosts for C. Neoehrlichia mikurensis. This role has been
described for infected voles, ﬁeld mice, wood mice, rats, and
even chipmunks, but not for shrews [1,12,31,50]. TheClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectprevalence rates of C. Neoehrlichia mikurensis infection among
rodents trapped in various parts of the world are shown in
Table 2. Hedgehogs are also potential reservoirs of C. Neo-
ehrlichia mikurensis, although their capacity to act as true
reservoirs of infection has not been tested [24]. If one com-
pares the prevalence rates of C. Neoehrlichia mikurensis in ticks
(Table 1) and in rodents (Table 2), it can be seen that they are
approximately two-fold higher among rodents. This has been
interpreted to support the concept that rodents are competent
hosts for C. Neoehrlichia mikurensis, perhaps being required
for the survival of C. Neoehrlichia mikurensis in the environ-
ment [31].
Kawahara et al. demonstrated rodent-to-rodent transmission
of C. Neoehrlichia mikurensis infection through intraperitoneal
injections of spleen homogenates from infected wild rats into
laboratory rats [1]. The ﬁrst evidence of C. Neoehrlichia
mikurensis infection was seen after 3 weeks (weak detection of
the pathogen in spleen samples with nested PCR). After 2ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 621–630
CMI Wennerås C. Neoehrlichia mikurensis 625months, the rats were unequivocally infected, showing strong C.
Neoehrlichia mikurensis-speciﬁc PCR reactivity in the spleen,
liver, and blood, without the need for nested PCR. The same
group failed to infect mice by inoculating C. Neoehrlichia
mikurensis-positive tick homogenates, although it is likely that
the mice were killed too early (after 10 days) for the infection
to be detected [1].
C. Neoehrlichia mikurensis is mainly detected in the spleen,
liver and kidneys of rodents, i.e. organs that are involved in the
clearance of systemic bacteria [1,12,25,43]. C. Neoehrlichia
mikurensis has also been detected in the brain and skin of ro-
dents [25,31,43]. There are no accounts of experimentally
infected rats being ill [1], and trapped, infected wild rodents
have not shown any apparent signs of disease (M. Andersson,
personal communication). In addition, rodents seem to clear
the infection within a few months, and are therefore not life-
long carriers of the infection [56]. However, a recent study
showed that fetuses and newborn pups of C. Neoehrlichia
mikurensis-infected wild rodents tested positive for C. Neo-
ehrlichia mikurensis, suggesting that transplacental transmission
of infection may occur [29]. Interestingly, rodents are re-
fractory to infection with the other Neoehrlichia species, C.
Neoehrlichia lotoris [8].
Apart from humans, the dog is the only animal known to
develop symptomatic C. Neoehrlichia mikurensis infection. This
is based on a single case report of an 8-year-old female Irish
Setter in Germany that was diagnosed with C. Neoehrlichia
mikurensis infection when she developed coagulopathy after
surgery for suspected mammary carcinoma [61]. The dog had
moderate thrombocytopenia but normal levels of coagulation
factors, and she subsequently became neutropenic [61]. Two
courses of antibiotics were required to clear the infection. It
was suggested that the dog was an asymptomatic carrier of C.
Neoehrlichia mikurensis, and that the active infection was
triggered by surgery-induced lowering of immune defence
mechanisms [61].Human C. Neoehrlichia mikurensis infectionThe ﬁrst reports of C. Neoehrlichia mikurensis infection in
humans in Europe were published in 2010 [11,35,52], 11 years
after the bacterium was ﬁrst described in ticks [3]. Although
human infection does not fulﬁll Koch’s Postulates, as the bac-
terium has not yet been cultivated, there are three compelling
lines of evidence for an aetiological linkage between the pres-
ence of C. Neoehrlichia mikurensis DNA in patient samples and
the development of infectious disease in immunocompromised
patients [62]: (a) high numbers of bacterial gene copies are seen
in the blood samples of diseased persons; (b) the infectiousClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologydisease resembles anaplasmosis/ehrlichiosis caused by related
species; and (c) targeted antibiotic therapy results in the res-
olution of symptoms and clearance of bacterial gene copies in
the bloodstream within days.
The clinical picture of neoehrlichiosis, which is the term
proposed to designate human infection with C. Neoehrlichia
mikurensis, is rather dramatic in immunocompromised patients
(Table 3). A high and remitting fever, which is often accom-
panied by chills and nightly sweats, is a characteristic ﬁnding
[10]. In many cases, there is severe pain, which may be localized
and/or migrating, and that may affect the neck, temporal/
mandibular joints, elbows, knees and ankles, muscles of the
trunk, or extremities. Skin rashes that resemble erysipelas or
erythema nodosum may develop. Less speciﬁc symptoms, such
as cough, diarrhoea, and weight loss resulting from protracted
systemic inﬂammation, may also occur (Table 3).
There is a remarkably high incidence of vascular and
thromboembolic events among the clinical signs of neo-
ehrlichiosis in patients in different European countries
(Table 3). These events may occur in the venous part of the
circulation, and may be manifested as deep vein thrombosis of
the extremities and/or pulmonary embolism. However,
thromboembolic events occurring in the arteries, e.g. transient
ischaemic attacks, which give rise to mental confusion, weak-
ness and numbness, are also seen. Ankle oedema and tender
subcutaneous veins are also noted, and may reﬂect vascular
reactions. It is not known whether these thromboembolic
complications result from inﬂamed and/or infected blood ves-
sels [10].
Although neoehrlichiosis afﬂicts immunocompromised in-
dividuals, it is premature to designate C. Neoehrlichia mikur-
ensis as an opportunistic pathogen. There are currently only
two studies of C. Neoehrlichia mikurensis infection in non-
immunocompromised persons [13,39] and two case reports
[11,35], representing 14 patients in total (Table 4). It could be
argued that one of these patients was immunocompromised
because of major surgery [35], similarly to the case of canine C.
Neoehrlichia mikurensis infection [61]. Of the more compre-
hensive studies on neoehrlichiosis in healthy subjects, one was a
hospital-based study of summer fever in tick-exposed persons
in north-eastern China [13], and the other was a surveillance
study of extensively tick-exposed forestry workers in Poland
[39].
The following host factors predispose patients to contracting
more severe neoehrlichiosis (Table 3): advanced age; a disease
that engages the adaptive immune system, either a haemato-
logical malignancy (malignant lymphoma or chronic lymphocytic
leukaemia) or an autoimmune/rheumatic disease (rheumatoid
arthritis, systemic lupus erythematosus, or psoriasis); and recent
chemotherapy or corticosteroid treatment [10]. Splenectomy isand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 621–630
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Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecta strong predisposing factor for severe disease, with the ma-
jority of immunocompromised patients with neoehrlichiosis
having undergone this procedure [10]. The importance of the
spleen probably reﬂects its capacity to produce natural IgM
antibodies, which constitute an important innate immune
defence mechanism [63].
The signiﬁcance of B-cells and/or antibodies in the host
defence against C. Neoehrlichia mikurensis is reinforced by the
ﬁnding that many patients with neoehrlichiosis have been
treated with rituximab (Table 3), a monoclonal antibody
directed against CD20 on B-cells [10,64]. The CD20 molecule
is expressed by all stages of B-cells, with the exception of
plasma cells, the producers of antibodies. Thus, rituximab-
treated patients, including those with neoehrlichiosis, may
present with normal levels of immunoglobulins in the serum
[64]. Rituximab is used to treat malignant lymphomas and
systemic rheumatic diseases. Physicians in charge of such pa-
tients in C. Neoehrlichia mikurensis-endemic regions should be
alert to the development of thromboembolic events, as this
may be a sign of neoehrlichiosis.
The clinical picture of C. Neoehrlichia mikurensis infection in
immunocompetent individuals is more diverse (Table 4), ranging
from asymptomatic infection [39] to febrile illness with a range of
associated symptoms [13], and a possibly fatal outcome [11]. The
prevalence of C.Neoehrlichia mikurensis infection in theChinese
study was 1.1% (seven of 622 patients); the rates of C. Neo-
ehrlichia mikurensis infection among ticks and rodents in the
same area were 1.6% and 3.8%, respectively [13]. In addition to
fever, all of the patients in that study reported headache and
malaise. Vomiting, nausea, myalgia and neck stiffness affected a
majority of the patients, whereas arthralgia, cough, diarrhoea,
confusion and erythema were observed less frequently (Table 4).
Whether or not the patients were treated with antibiotics and
how rapidly they cleared and recovered from the infection were
not reported. A very similar rate of C. Neoehrlichia mikurensis
infection was seen in the Polish study, i.e. 1.6% (ﬁve of 316 pa-
tients) [39]. In contrast to the participants in theChinese study, all
ﬁve individuals in the Polish studywho had positive blood samples
were asymptomatic (Table 4).
The incubation period between exposure to C. Neoehrlichia
mikurensis and symptomatic infection is uncertain. Li et al. re-
ported that the median time from tick bite to onset of illness in
their patients was 8 days (range, 2–35 days) [13]. However, this
is a gross estimate, as the ticks were not collected and analysed
for the presence of C. Neoehrlichia mikurensis, and it is likely
that these patients (all of whom were farmers) had been sub-
jected to repeated and unnoticed tick bites [13].
Typical laboratory ﬁndings in immunocompromised patients
with neoehrlichiosis are elevated white blood cell counts, neu-
trophilia, increases in the levels of inﬂammatory markers, such asious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 621–630
TABLE 4. Candidatus Neoehrlichia mikurensis infection in immunocompetent patients
Demographic and host factors Clinical picture
ReferencesCountry
No. of
patients F/M ratio
Age in years
(range) Other disease Tick-bitten
Fever,
no. (%)
Myalgia/
arthralgia,
no. (%)
Skin rash,
no. (%)
Vascular/thromboembolic
events
Germany 1 0/1 57 No 0/1 1/1 0/1 0/1 Aneurysm of cerebral artery
Cerebral haemorrhage and
infarction
[11]
Switzerland 1 0/1 61 Post-CABG and
mitral valve surgery
0/1 1/1 0/1 0/1 Prophylactic anticoagulant therapy [35]
China 7 2/5 41 (29–67) No 7/7 7/7 4/7 1/7 Confusion in one patient [13]
Poland 5 1/4 ND No 5/5 0/5 0/5 0/5 No [39]
Total 14 79% M 12/14 (86) 9/14 (64) 4/14 (29) 1/14 (7)
CABG, coronary artery bypass graft; F, female; M, male; ND, not described.
CMI Wennerås C. Neoehrlichia mikurensis 627C-reactive protein, procalcitonin, and erythrocyte sedimenta-
tion rate [36], and anaemia [10]. Occasionally, modest throm-
bocytopenia, lymphopenia and hyponatraemia, slightly elevated
levels of hepatic transaminases, and increased levels of lactate
dehydrogenase are seen [10]. The two reports on immuno-
competent patients show a similar proﬁle, i.e. leukocytosis
[11,35], neutrophilia [35], and raised serum C-reactive protein
[11,35]. In contrast, Li et al. reported that ﬁve of seven of their
patients had normal leukocyte counts, and that the remaining
two patients had leukocytosis and leukopenia, respectively [13].
In addition, anaemia and thrombocytopenia occurred in two
patients, although it was not speciﬁed whether these were the
same patients who had altered leukocyte counts [13].DiagnosticsAlthough C. Neoehrlichia mikurensis was described in The
Netherlands 15 years ago [3], and it is appreciated that every
ninth Dutch tick bite carries the risk of C. Neoehrlichia
mikurensis transmission [59], not a single case of neo-
ehrlichiosis has been reported from that country. It is likely that
cases have been missed because of diagnostic limitations. Pa-
tients diagnosed with neoehrlichiosis have, as a rule, been
subjected to numerous investigations to ﬁnd the cause of their
fever, leading to considerable delays in diagnosis (median of 60
days) [10]. These patients have also, without exception, been
treated unsuccessfully with various broad-spectrum antibiotics
before the correct diagnosis has been reached [10].
Currently, the only diagnostic option for C. Neoehrlichia
mikurensis infection is PCR. Three types of PCR have been
used to detect C. Neoehrlichia mikurensis in human samples:
pan-bacterial PCR directed against the 16S rRNA gene
[11,35,52]; nested PCR speciﬁc for the 16S rRNA gene of
Anaplasmataceae [13]; and C. Neoehrlichia mikurensis-speciﬁc
PCR targeting the 16S rRNA gene or groESL gene [10,64].
The ﬁrst two types of PCR require sequencing of the ﬂankingClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologygene segments. A multiplex PCR has been developed that in-
corporates probes speciﬁc for the Anaplasmataceae family,
Neoehrlichia genus, and C. Neoehrlichia mikurensis, enabling the
detection of all three targets in a single reaction [36]. Positive
control plasmids that contain regions of the C. Neoehrlichia
mikurensis 16S rRNA gene have been included in the PCRs
[10,36]. These assays have shown that immunocompromised
patients have high bacterial burdens, with the highest detected
loads being 3 × 107 gene copies/mL in the bone marrow and
9 × 106 gene copies/mL in the blood of a splenectomized pa-
tient with chronic lymphocytic leukaemia [36].
Two types of human sample have yielded positive PCR re-
sults in neoehrlichiosis patients: blood (plasma, serum, whole
blood, and blood culture ﬂask contents) and bone marrow [10].
Even though mental confusion and other neurological symp-
toms have been observed in a few patients with neoehrlichiosis,
C. Neoehrlichia mikurensis DNA has not been detected in the
cerebrospinal ﬂuids of such patients [10].
C. Neoehrlichia mikurensis has not been cultivated, its
genome has not been sequenced, and its surface antigens
remain unknown, so serological assays are not available.
Although it is claimed that there is no serological cross-
reactivity between C. Neoehrlichia mikurensis and
E. chaffeensis and/or A. phagocytophilum, this is mainly based on
studies of immunocompromised patients, who may be inca-
pable of producing antibodies in response to infection. There is
one report of an immunocompetent neoehrlichiosis patient
who apparently developed IgM antibodies cross-reactive to
A. phagocytophilum, which gave an atypical pattern in the indirect
ﬂuorescence assay that was employed, and a low IgG titre [35].
The patient tested negative in an A. phagocytophilum PCR [35].TreatmentDoxycycline is active against intracellular bacteria, and is rec-
ommended for the treatment of neoehrlichiosis. Oraland Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 621–630
628 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIadministration of 100 mg of doxycycline twice daily has been
used for almost every published case of neoehrlichiosis.
Rifampin (300 mg twice daily) was used successfully in a patient
with suspected hypersensitivity to doxycycline (own unpub-
lished observation), and another patient was treated success-
fully with a combination of rifampin (450 mg twice daily) and
doxycycline (100 mg twice daily) [35]. The optimal length of
time for which treatment should be given for neoehrlichiosis is
not known. Most studies report a treatment duration of 3
weeks [10], although shorter (2 weeks) [64] and considerably
longer (6 weeks) courses of treatment have been used [35].
Importantly, all known cases of immunocompromised patients
with neoehrlichiosis who were treated with adequate antibi-
otics improved rapidly, with a median time to resolution of
symptoms of 5 days, and all survived, with follow-up PCR an-
alyses of their blood samples for C. Neoehrlichia mikurensis
yielding negative results [10,64].ConclusionAlthough much knowledge has been gained during the last few
years, since we learned that C. Neoehrlichia mikurensis can
cause human disease, much remains to be resolved. We need
to learn how to cultivate it, to be able to sequence its genome
and study host–pathogen interactions at the cellular level.
Nothing is known regarding its virulence factors, and very little
is known regarding its immunopathogenic mechanisms. Sero-
logical assays are needed to establish the degree of exposure of
people (and dogs) to this new pathogenic species, and deter-
mine its impact on public health. The ﬁeld of C. Neoehrlichia
mikurensis research is wide open, and will hopefully reveal
many exciting ﬁndings in the near future.Transparency declarationThe author declares that she has no conﬂicts of interest.References[1] Kawahara M, Rikihisa Y, Isogai E, Takahashi M, Misumi H, Suto C, et al.
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